We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Shenzhen YHLO Biotech Co., Ltd.

Shenzhen YHLO Biotech Co., Ltd. (YHLO) is an immunoassay solutions company that specializes in developing, manufactur... read more Featured Products: More products

Download Mobile App





YHLO Unveils Total Laboratory Automation System for Elevated Laboratory Efficiency

By LabMedica International staff writers
Posted on 05 Feb 2025

YHLO (Shenzhen, China) is presenting iTLA Max, its total laboratory automation system designed to enhance laboratory workflows and optimize performance. More...

YHLO's independently developed iTLA MAX laboratory automation system is designed to address practical issues in medical laboratories, integrating innovative technology into every aspect of laboratory work, from pre-analysis to analysis and post-analysis, achieving comprehensive intelligent connectivity. It plays a significant role in improving clinical laboratory testing efficiency, enhancing departmental management capabilities, and advancing the development of laboratory science. The iTLA MAX laboratory automation system is composed of units such as sampling, centrifugation, capping, rack connection, track, and output, offering unprecedented convenience and efficiency in sample processing through its intelligent and efficient modular design. The 360-degree ring light design ensures that laboratory personnel can observe the equipment's operating status from any angle, providing strong support for laboratory safety management. The waterfall-style screen design, combined with ergonomic standards, adjusts the screen height to ensure user comfort during operation. The intelligent information management system integrates multiple functions such as operation control, data processing, alarm prompts, and query statistics, providing laboratory personnel with an intuitive and convenient interface.

YHLO’s iFlash series chemiluminescence immunoassay analyzers, highly acclaimed in the industry for their exceptional accuracy and rapid processing speed, were prominently featured at the exhibition. In addition to its leading self-immunity diagnostic products, YHLO highlighted its new biochemistry-immunoassay integrated analyzer along with a comprehensive suite of over 100 testing assays. As a major player in China’s IVD industry, YHLO offers a wide array of testing solutions covering self-immunity, infectious disease, reproductive health, liver disease, respiratory conditions, and cardiovascular diagnostics, among others. The new integrated analyzer provides laboratories with more flexible testing options.


Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
UHF RFID Tag & Inlay
AD-327 U9 ETSI Pure 95
New
Mini Vortex Mixer
Vornado
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.